EISAI CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,560 JPY | -1.00% |
|
-1.01% | -6.98% |
| Jul. 02 | Eli Lilly Alzheimer's drug approved by US FDA | RE |
| Jul. 02 | Eisai Repurchases 4.8 Billion Yen Worth of Shares in June | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Eisai Company specializes in the manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical products (87.7%): prescribed drugs, health products, etc.;
- other (12.3%): food additives, chemical products, etc.
Net sales are distributed geographically as follows: Japan (46.2%), Europe (19.5%), Americas (15.5%), China (10.3%) and other (8.4%).
Sector
Pharmaceuticals
Calendar
2024-11-05
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
6,626
JPY
Average target price
8,138
JPY
Spread / Average Target
+22.82%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -6.98% | 11.73B | |
| +55.55% | 816B | |
| +40.74% | 634B | |
| -6.83% | 351B | |
| +17.15% | 323B | |
| +7.09% | 293B | |
| +13.49% | 238B | |
| +1.47% | 222B | |
| +13.63% | 218B | |
| +7.87% | 167B |
- Stock Market
- Equities
- 4523 Stock
- News Eisai Co., Ltd.
- Eisai Repurchases 4.8 Billion Yen Worth of Shares in June
